Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands

Autor: Hinsenveld, Florentien J., Boormans, Joost L, van der Poel, Henk G, van der Schoot, Deric K E, Vis, André N, Aben, Katja K H, Arends, TJ, Ausems, PJ, Baselmans, D, Berger, CPAM, Berrens, A, Bickerstaffe, H, Bos, SD, Braam, M, Buddingh, KT, Claus, S, Dekker, K, van Doeveren, T, Einerhand, SMH, Fossion, LMCL, van Gennep, EJ, van Ginkel, N, Palacios, LA Grondhuis, Hermans, TJN, Hobijn, MM, van Huystee, SH, Jaspers-Valentijn, M, Klaver, OS, Koldewijn, EL, Korsten, L, Lenting, A, Lentjes, KJ, Luiting, HB, van der Meer, S., Nieuwenhuijzen, JA, Noordzij, MA, Nooter, RI, Notenboom, CAW, Oomen, RJA, van Roermund, JGH, de Rooij, J, Roshani, H, Schrier, BP, van der Slot, MA, Somford, DM, Stelwagen, PJ, Stroux, AMA, van der West, A, Wijsman, BP, Windt, WAKM, van Zanten, P, van Beek, Sytse C

Publikováno v: In Urologic Oncology: Seminars and Original Investigations February 2022 40(2):60-60

Validation of Claims Data for Absorbing Pads as a Measure for Urinary Incontinence after Radical Prostatectomy, a National Cross-Sectional Analysis.

Autor: Baas DJH; Department of Urology, Canisius Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands.; Prosper Prostate Cancer Clinics, 6532 SZ Nijmegen, The Netherlands., Reitsma J; Zorgverzekeraars Nederland, 3700 AM Zeist, The Netherlands., Gerwen LV; Vektis Intelligence, Vektis, 3700 AS Zeist, The Netherlands., Vleghaar J; Vektis Intelligence, Vektis, 3700 AS Zeist, The Netherlands., Gehlen JMLG; CZ Zorgverzekeringen, 5038 KE Tilburg, The Netherlands., Ziedses des Plantes CMP; Zilveren Kruis, 3833 LB Leusden, The Netherlands., van Basten JPA; Department of Urology, Canisius Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands.; Prosper Prostate Cancer Clinics, 6532 SZ Nijmegen, The Netherlands., van den Bergh RCN; Department of Urology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., Bruins HM; Department of Urology, Zuyderland Medical Center, 6419 PC Heerlen, The Netherlands., Collette ERP; Department of Urology, Bravis Hospital, 4624 VT Bergen op Zoom, The Netherlands., Hoekstra RJ; Prosper Prostate Cancer Clinics, 6532 SZ Nijmegen, The Netherlands.; Department of Urology, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands., Knipscheer BC; Department of Urology, Treant Zorggroep, 7824 AA Emmen, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Luijendijk-de Bruin D; Department of Urology, Martini Hospital, 9728 NT Groningen, The Netherlands., van Roermund JGH; Department of Urology, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands., Sedelaar JPM; Prosper Prostate Cancer Clinics, 6532 SZ Nijmegen, The Netherlands.; Department of Urology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Speel TGW; Department of Urology, Leeuwarden Medical Center, 8934 AD Leeuwarden, The Netherlands., Stomps SP; Department of Urology, Ziekenhuisgroep Twente, 7609 PP Almelo, The Netherlands., Wijburg CJ; Department of Urology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands., Wijn RPWF; Department of Urology, Jeroen Bosch Hospital, 5223 GZ Hertogenbosch, The Netherlands., de Jong IJ; Department of Urology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands.; Prosper Prostate Cancer Clinics, 6532 SZ Nijmegen, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2023 Dec 07; Vol. 15 (24). Date of Electronic Publication: 2023 Dec 07.

Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients.

Autor: Overkamp M; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research & Development, Utrecht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.; TiFN, Wageningen, The Netherlands., Houben LHP; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research & Development, Utrecht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.; TiFN, Wageningen, The Netherlands., van der Meer S; Department of Urology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., van Roermund JGH; Department of Urology, Maastricht University Medical Center+, Maastricht, The Netherlands., Bos R; Department of Urology, Zuyderland Medical Center, Heerlen, The Netherlands., Kokshoorn APJ; Sports Medical Center, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Larsen MS; Arla Foods Ingredients Group P/S, Viby J, Denmark., van Loon LJC; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.; TiFN, Wageningen, The Netherlands., Beelen M; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.; TiFN, Wageningen, The Netherlands., Beijer S; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research & Development, Utrecht, The Netherlands.; TiFN, Wageningen, The Netherlands.

Publikováno v: Scandinavian journal of urology [Scand J Urol] 2023 Feb-Dec; Vol. 57 (1-6), pp. 60-66. Date of Electronic Publication: 2023 Jan 26.

Management of upper urinary tract problems after radical cystectomy for urothelial carcinoma: tips and tricks.

Autor: van 't Hof MEM; Department of Urology, Maastricht University Medical Centre +, Maastricht., Bruins HM; Department of Urology, Zuyderland Hospital, Heerlen, The Netherlands., van Roermund JGH; Department of Urology, Maastricht University Medical Centre +, Maastricht.

Publikováno v: Current opinion in urology [Curr Opin Urol] 2021 Nov 01; Vol. 31 (6), pp. 570-573.

Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.

Autor: Waltman CG; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands., Marcelissen TAT; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands., van Roermund JGH; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: joep.van.roermund@mumc.nl.

Publikováno v: European urology focus [Eur Urol Focus] 2020 Nov 15; Vol. 6 (6), pp. 1220-1225. Date of Electronic Publication: 2018 Nov 24.